Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levetiracetam for cognitive symptoms in schizophrenia
IRCT20101130005280N32Phase 2Completed
- Sponsor
- Mashhad University of Medical Sciences
- Start
- Oct 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, double-blind trial of levetiracetam in schizophrenia (2 arms), sponsored by Mashhad University of Medical Sciences. Primary endpoint: cognitive function. Started Oct 2019; status: completed.
02
Drugs
levetiracetam
03
Conditions
schizophrenia
Beyond the preview
Go deeper on IRCT20101130005280N32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20101130005280N32.